These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of methylphenidate on ICU and hospital length of stay in patients with severe and moderate traumatic brain injury. Moein H, Khalili HA, Keramatian K. Clin Neurol Neurosurg; 2006 Sep; 108(6):539-42. PubMed ID: 16226371 [Abstract] [Full Text] [Related]
3. Methylphenidate and amantadine to stimulate reawakening in comatose patients resuscitated from cardiac arrest. Reynolds JC, Rittenberger JC, Callaway CW. Resuscitation; 2013 Jun; 84(6):818-24. PubMed ID: 23178867 [Abstract] [Full Text] [Related]
4. [Paradoxical effect of methylphenidate in the treatment of a patient with severe traumatic brain injury]. Grønborg P, Liljegren J, Jansen J. Ugeskr Laeger; 2009 Jun 22; 171(26):2201-2. PubMed ID: 19671403 [Abstract] [Full Text] [Related]
5. The effect of methylphenidate on the sleep-wake cycle of brain-injured patients undergoing rehabilitation. Al-Adawi S, Burke DT, Dorvlo AS. Sleep Med; 2006 Apr 22; 7(3):287-91. PubMed ID: 16564212 [Abstract] [Full Text] [Related]
6. Use of methylphenidate in traumatic brain injury. Siddall OM. Ann Pharmacother; 2005 Apr 22; 39(7-8):1309-13. PubMed ID: 15914519 [Abstract] [Full Text] [Related]
9. Ritalin revisited: does it really help in neurological injury? Kajs-Wyllie M. J Neurosci Nurs; 2002 Dec 22; 34(6):303-13. PubMed ID: 12506813 [Abstract] [Full Text] [Related]
13. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Carpentier PJ, de Jong CA, Dijkstra BA, Verbrugge CA, Krabbe PF. Addiction; 2005 Dec 22; 100(12):1868-74. PubMed ID: 16367988 [Abstract] [Full Text] [Related]
14. Therapeutic options to enhance coma arousal after traumatic brain injury: state of the art of current treatments to improve coma recovery. Cossu G. Br J Neurosurg; 2014 Apr 22; 28(2):187-98. PubMed ID: 24090192 [Abstract] [Full Text] [Related]
15. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Butler JM, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG. Int J Radiat Oncol Biol Phys; 2007 Dec 01; 69(5):1496-501. PubMed ID: 17869448 [Abstract] [Full Text] [Related]